Sex, androgens and regulation of pulmonary AR, TMPRSS2 and ACE2.


Journal

bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187

Informations de publication

Date de publication:
14 Oct 2020
Historique:
entrez: 21 10 2020
pubmed: 22 10 2020
medline: 22 10 2020
Statut: epublish

Résumé

The sex discordance in COVID-19 outcomes has been widely recognized, with males generally faring worse than females and a potential link to sex steroids. A plausible mechanism is androgen-induced expression of TMPRSS2 and/or ACE2 in pulmonary tissues that may increase susceptibility or severity in males. This hypothesis is the subject of several clinical trials of anti-androgen therapies around the world. Here, we investigated the sex-associated TMPRSS2 and ACE2 expression in human and mouse lungs and interrogated the possibility of pharmacologic modification of their expression with anti-androgens. We found no evidence for increased

Identifiants

pubmed: 33083800
doi: 10.1101/2020.04.21.051201
pmc: PMC7574256
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NHLBI NIH HHS
ID : P01 HL103453
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA172382
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA236780
Pays : United States
Organisme : NHLBI NIH HHS
ID : UG1 HL139126
Pays : United States

Commentaires et corrections

Type : UpdateIn

Références

Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
J Med Virol. 2020 Apr 15;:
pubmed: 32293753
Mol Cell. 2007 Aug 3;27(3):380-92
pubmed: 17679089
Cancer Discov. 2020 Jun;10(6):779-782
pubmed: 32276929
Eur Respir J. 2020 May 14;55(5):
pubmed: 32269089
J Urol. 2020 Sep 8;:101097JU0000000000001338
pubmed: 32897764
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
Hum Pathol. 1995 Mar;26(3):291-4
pubmed: 7890280
Dev Cell. 2020 Jun 8;53(5):514-529.e3
pubmed: 32425701
Mol Cell Endocrinol. 2010 Apr 12;317(1-2):14-24
pubmed: 20035825
Ann Oncol. 2020 Aug;31(8):1040-1045
pubmed: 32387456
J Clin Endocrinol Metab. 2003 May;88(5):2309-17
pubmed: 12727990
Proc Natl Acad Sci U S A. 2020 Jan 28;117(4):2187-2193
pubmed: 31932420
Ann Oncol. 2020 Mar;31(3):369-376
pubmed: 32057540
Intensive Care Med. 2020 Apr;46(4):586-590
pubmed: 32125455
J Clin Med. 2020 Mar 20;9(3):
pubmed: 32244852
J Clin Pathol. 1995 Sep;48(9):876-8
pubmed: 7490328
Mol Cell Biol. 2006 Feb;26(3):965-75
pubmed: 16428450
Science. 2005 Oct 28;310(5748):644-8
pubmed: 16254181
Endocr Relat Cancer. 2020 Apr 1;27(6):E1-E3
pubmed: 32302975
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508
Mol Endocrinol. 1995 Feb;9(2):208-18
pubmed: 7776971

Auteurs

Mehdi Baratchian (M)

Genitourinary Malignancies Research Center, Lerner Research Institute, Cleveland Clinic.

Jeffrey M McManus (JM)

Genitourinary Malignancies Research Center, Lerner Research Institute, Cleveland Clinic.

Mike Berk (M)

Genitourinary Malignancies Research Center, Lerner Research Institute, Cleveland Clinic.

Fumihiko Nakamura (F)

Genitourinary Malignancies Research Center, Lerner Research Institute, Cleveland Clinic.

Sanjay Mukhopadhyay (S)

Pathology and Laboratory Medicine Institute, Cleveland Clinic.

Weiling Xu (W)

Department of Pathobiology, Lerner Research Institute, Cleveland Clinic.
Respiratory Institute, Cleveland Clinic.

Serpil Erzurum (S)

Department of Pathobiology, Lerner Research Institute, Cleveland Clinic.
Respiratory Institute, Cleveland Clinic.

Judy Drazba (J)

Imaging Core, Lerner Research Institute, Cleveland Clinic.

John Peterson (J)

Imaging Core, Lerner Research Institute, Cleveland Clinic.

Eric A Klein (EA)

Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic.

Ben Gaston (B)

Herman Wells Center for Pediatric Research, Indiana University School of Medicine.

Nima Sharifi (N)

Genitourinary Malignancies Research Center, Lerner Research Institute, Cleveland Clinic.
Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic.
Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic.

Classifications MeSH